UNITED THERAPEUTICS Corp ($UTHR)
Filing Information
| Accession Number | 0001231589-26-000012 |
|---|---|
| Form Type | 4 |
| Filing Date | May 21, 2026 |
| Document | View SEC Filing |
Transactions
13
Total Shares
24,900
Total Value
$5,883,448.11
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP & GENERAL COUNSEL | Common Stock | โ | May 21, 2026 | Exercise/Conversion | 300 | $146.03 | $43,809.00 | 45,472 | Direct | โ | View Details | |
EVP & GENERAL COUNSEL | Common Stock | โ | May 21, 2026 | Exercise/Conversion | 8,000 | $146.03 | $1,168,240.00 | 53,472 | Direct | โ | View Details | |
EVP & GENERAL COUNSEL | Common Stock | โ | May 21, 2026 | Sale | 110 | $555.72 | $61,129.34 | 53,362 | Direct | โ | View Details | |
EVP & GENERAL COUNSEL | Common Stock | โ | May 21, 2026 | Sale | 10 | $556.70 | $5,567.00 | 53,352 | Direct | โ | View Details | |
EVP & GENERAL COUNSEL | Common Stock | โ | May 21, 2026 | Sale | 640 | $557.85 | $357,024.00 | 52,712 | Direct | โ | View Details | |
EVP & GENERAL COUNSEL | Common Stock | โ | May 21, 2026 | Sale | 200 | $559.99 | $111,998.00 | 52,512 | Direct | โ | View Details | |
EVP & GENERAL COUNSEL | Common Stock | โ | May 21, 2026 | Sale | 2,178 | $561.99 | $1,224,014.66 | 50,334 | Direct | โ | View Details | |
EVP & GENERAL COUNSEL | Common Stock | โ | May 21, 2026 | Sale | 1,326 | $562.93 | $746,449.29 | 49,008 | Direct | โ | View Details | |
EVP & GENERAL COUNSEL | Common Stock | โ | May 21, 2026 | Sale | 2,015 | $564.06 | $1,136,573.44 | 46,993 | Direct | โ | View Details | |
EVP & GENERAL COUNSEL | Common Stock | โ | May 21, 2026 | Sale | 1,251 | $565.20 | $707,059.07 | 45,742 | Direct | โ | View Details | |
EVP & GENERAL COUNSEL | Common Stock | โ | May 21, 2026 | Sale | 270 | $566.05 | $152,834.31 | 45,472 | Direct | โ | View Details | |
EVP & GENERAL COUNSEL | Common Stock | โ | May 21, 2026 | Sale | 300 | $562.50 | $168,750.00 | 45,172 | Direct | โ | View Details | |
EVP & GENERAL COUNSEL | Stock Option | Derivative | May 21, 2026 | Exercise/Conversion | 8,300 | $0.00 | $0.00 | 113,940 | Direct | โ | View Details |